Aqr Capital Management LLC Syros Pharmaceuticals, Inc. Transaction History

Aqr Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.69 - $1.21 $53,830 - $94,398	78,015 Added 418.63%	96,651 $93,000
Q1 2022 May 16, 2022	BUY	$1.02 - $3.8 $19,008 - $70,816	18,636 New	18,636 $22,000
Q2 2021 Aug 16, 2021	SELL	$5.01 - $7.48 $98,536 - $147,116	-19,668 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$7.19 - $14.95 $51,976 - $108,073	-7,229 Reduced 26.88%	19,668 $147,000
Q4 2020 Feb 16, 2021	SELL	$6.66 - $14.66 $129,430 - $284,902	-19,434 Reduced 41.95%	26,897 $292,000
Q3 2020 Nov 16, 2020	BUY	$8.69 - $14.47 $62,594 - $104,227	7,203 Added 18.41%	46,331 $410,000
Q2 2020 Aug 17, 2020	BUY	$5.21 - $11.03 $127,639 - $270,223	24,499 Added 167.47%	39,128 $417,000
Q1 2020 May 15, 2020	BUY	$4.46 - $9.2 $65,245 - $134,586	14,629 New	14,629 $87,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.